Status: Recruiting
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
RADIATE-VT is a pivotal, multicenter, randomized trial comparing safety and efficacy between cardiac radioablation (CRA) using the Varian CRA System and repeat catheter ablation (CA), for patients with high-risk refractory ventricular tachycardia (VT) who have experienced VT recurrence after CA and are candidates for additional CA.
Participants needed: 380
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Varian, a Siemens Healthineers CompanyUpdated: Apr 22, 2026Locations: 11
Eligibility criteria
Ischemic and/or nonischemic cardiomyopathy, and [+9]
Contraindication to a CA procedure for VT (e.g., presence of mobile LV thrombus,... [+19]